James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 93,414 shares at $43.87 ($4.3M) on 2018-06-04, disclosed to the SEC on 2018-06-06.
Open-market sale of $4.3M GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.41 | 10,000 | $434K | 10.2% |
| 2 | $43.42 | 8,594 | $373K | 8.7% |
| 3 | $43.54 | 4,052 | $176K | 4.1% |
| 4 | $43.87 | 9,000 | $395K | 9.2% |
| 5 | $44.67 | 10,977 | $490K | 11.5% |
| 6 | $45.47 | 2,523 |
| $115K |
| 2.7% |
| 7 | $46.07 | 7,552 | $348K | 8.1% |
| 8 | $46.83 | 12,448 | $583K | 13.6% |
| 9 | $47.57 | 9,639 | $459K | 10.7% |
| 10 | $48.33 | 6,629 | $320K | 7.5% |
| 11 | $48.57 | 12,000 | $583K | 13.6% |
| Total | $45.78 avg | 93,414 | $4.3M | 100% |
| Filing → |
| GHDX | SELL | 2019-06-10 | $459K | — | Filing → |
| GHDX | SELL | 2019-05-10 | $421K | — | Filing → |
| GHDX | SELL | 2018-10-10 | $3.2M | — | Filing → |